Shanghai Changjiang Guohong Investment Management
Grand Yangtze Capital is a professional equity investment management organization.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Shanghai Changjiang Guohong Investment Management Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Grand Yangtze Capital is an investment firm focused principally on equity investments in growth and expansion stage enterprises in China. They have been managing 7 PE and VC funds since 2007 and have deployed over 4 billion RMB. Grand Yangtze Capital has invested in over 40 companies, among which 8 companies went public, and several others were merged or acquired, e.g. Sino-Crystal (300064), Shuanghuan(002472), Hainan Rubber(601118), HLBN(300291), ZMJ(601717), China UMS, ZBT Pharma, ELLASSAY(603808), B-Soft(300451), Guochuang Software(300520), YMatou, Pharma Block, etc.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2018 | Jiean Hi-Tech | Post-IPO Equity | 6.6M |
| 4/2018 | S.POINT | Series B | 3.2M |
| 12/2013 | LUOSHI | Angel Round | 492.8k |
| 3/2019 | TBSTest Technology | Series A | 10M |
| 6/2011 | Lekan.com | Venture Round | - |
| 11/2021 | Vision Semiconductor Technology | Series A | 15.7M |
| 3/2021 | Aucta Pharmaceuticals China | Series A | - |
| 12/2019 | Licai Mofang | Series A | 11M |
| 4/2015 | MULTi DiMENSiON | Series B | 3.2M |
| 10/2016 | Qingyan Keji | Series A | 1.5M |
| 1/2014 | ECN Game | Series B | 3.3M |
| 5/2016 | Yi Kang Zhimian | Series A | 1.5M |
| 5/2019 | Raise3D | Series B | - |
| 6/2022 | YunLSP | Series B | 15M |
| 7/2014 | CKW | Angel Round | 4M |
| 9/2020 | InxMed | Series A | 0 |
| 5/2010 | MULTi DiMENSiON | Angel Round | 439.4k |
| 3/2022 | Yaotan Pharmaceutical | Series A | 0 |
| 12/2019 | Tongtongeyan | Venture Round | 7.1M |
| 3/2020 | CRP Robot | Series B | 14.4M |
| 9/2019 | Stroke Medical | Series B | 14.1M |
| 6/2022 | YunLSP | Series B | 0 |
| 3/2022 | Yaotan Pharmaceutical | Series A | 0 |
| 11/2021 | Vision Semiconductor Technology | Series A | 0 |
| 3/2021 | Aucta Pharmaceuticals China | Series A | - |
| 9/2020 | InxMed | Series A | 0 |
| 3/2020 | CRP Robot | Series B | 0 |
| 12/2019 | Tongtongeyan | Venture Round | 0 |
| 12/2019 | Licai Mofang | Series A | 0 |
| 9/2019 | Stroke Medical | Series B | 0 |
| 5/2019 | Raise3D | Series B | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
